Skip to main content
TipRanks
Go Ultimate75% OFF

Elan Corp Plc Insider Profile

4 Followers

Elan Corp Plc, Ten Percent Owner at Lipocine, holds 800.39K shares in Lipocine (Ticker: LPCN), holds 3.18M shares in Prothena (Ticker: PRTA), holds 7.75M shares in Alkermes (Ticker: ALKS). Most recently, Elan Corp Plc Bought ― shares of Lipocine on Aug 02, 2013 for an estimated value of ―.

Elan Corp Plc's Trading History

LPCN
Lipocine
Aug 02, 2013Ten Percent OwnerInformative Buy―$1.37M
PRTA
Prothena
Dec 28, 2012Ten Percent OwnerInformative Buy―$25.97M
ALKS
Alkermes
Mar 14, 2012Ten Percent OwnerInformative Sell381.57M$364.48M
LGND
Ligand Pharma
―Ten Percent Owner―$0.00
SNGX
Soligenix
―Ten Percent Owner―$52.19K
TGEN
Tecogen
―Ten Percent Owner―$23.04M

You May Also Like

Elan Corp Plc insider profile FAQ

What is the percentage of profitable transactions made by Elan Corp Plc?
The percentage of profitable transactions made by Elan Corp Plc is 50%.
What is the average return per transaction made by Elan Corp Plc?
The average return per transaction made by Elan Corp Plc is 43.70%.
What stocks does Elan Corp Plc hold?
Elan Corp Plc holds: LPCN, ALKS, TGEN, PRTA, SNGX, LGND stocks.
What was Elan Corp Plc's most profitable transaction?
Elan Corp Plc’s most profitable transaction was an Informative Buy of PRTA stock on December 28, 2012. The return on the trade was 295.90%.
What is Elan Corp Plc's role in Lipocine?
Elan Corp Plc's role in Lipocine is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.